5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The Market is Segmented by Products (Drugs and Devices) and Gender.
An unintended pregnancy occurs from not using contraception or by inconsistent and incorrect use of contraceptive methods. The growth of the contraceptives markets is the necessity to avoid unwanted pregnancies and their complications, especially in teenagers. Teenage pregnancy is a big problem in Africa. The Limpopo Department of Health has estimated that around 182,000 South African teenagers are found becoming pregnant each year. Pregnant teenagers face serious health, socio-economic, and educational challenges. According to an article by Jyothi Laldas in 2018, girls between the ages of 15 and 19-years old accounted for 11% of births worldwide. Of this, almost 95% of births are in low- to middle-income countries. An increase in unplanned pregnancies has helped in the growth of the market. The other factors, such as the increasing incidence of the STDs and the rise in government initiatives, are also expected to propel the market growth over the forecast period.
As per the scope of the report, contraceptive drugs and devices are used for birth control. Contraception is more commonly known as fertility and birth control, which is described as the method to avoid pregnancy.
Report scope can be customized per your requirements. Click here.
Based on drugs, the market is segmented into oral contraceptives, topical contraceptives and contraceptive injectable. Oral contraceptive pills are considered as the easiest method of contraception in the industry. They act by prohibiting implantation within the uterus if taken within 2-3 days of having unsafe sexual contact. These are easily marketed across large regions by several companies and thus easily consumed by a large section of the population. According to WHO, in 2018, around 214 million women of reproductive age in developing countries who want to avoid pregnancy are not using a modern contraceptive method. In Africa, 24.2% of women of reproductive age have an unmet need for modern contraception, as per the WHO estimates. Hence, the rising demand for contraceptives to avoid unintended pregnancies, along with rising government initiatives, is expected to drive the market in the forecast period.
To understand key trends, Download Sample Report
The market studied is moderately competitive, and there are several local as well as international companies in Africa that deal with the contraceptives. The major players in the Africa contraceptive drugs and devices market are Allergan PLC, Bayer AG, Johnson & Johnson, Lupin Limited, Merck & Co. Inc., Mylan NV, Pfizer Inc., and Teva Pharmaceutical Industries Ltd.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidence of the STDs
4.2.2 Increase in Unplanned Pregnancies
4.2.3 Rise in Government Initiatives
4.3 Market Restraints
4.3.1 Side Effects Associated with the Use of Contraceptive Drugs and Devices
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Products
5.1.1 By Drugs
126.96.36.199 Oral Contraceptives
188.8.131.52 Topical Contraceptives
184.108.40.206 Contraceptive Injectable
5.1.2 By Device
220.127.116.11 Cervical Caps
18.104.22.168 Vaginal Rings
22.214.171.124 Other Devices
5.2 By Gender
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Allergan PLC
6.1.2 Bayer AG
6.1.3 Johnson & Johnson
6.1.4 Lupin Limited
6.1.5 Merck & Co. Inc.
6.1.6 Mylan N.V.
6.1.7 Pfizer Inc.
6.1.8 Teva Pharmaceutical Industries Ltd
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments